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Abstract
Introduction: Plasma lactate is a frequently used and important parameter for medical decision making. To setup a pre-analytical algorithm, we 
aimed to investigate the influence of different test tube additives, aliquoting, ice storage and haemolysis on plasma lactate concentrations for possi-
ble sparing critically ill (ICU) patients of additional blood drawing.
Materials and methods: In our study (N = 177), lactate concentration and haemolysis index (HI) were measured in aliquoted (AHP) and una-
liquoted (HP) Li-heparin, NaF/K3EDTA and NaF/KOX plasma, centrifuged within 15 minutes after venipuncture, on Cobas c501 analyzer. Differences 
were tested using the Wilcoxon’s test and Passing-Bablok regression. Clinical accuracy of results was assessed in 107 ICU patients based on reference 
interval and clinical decision limits. 
Results: Lactate concentrations did not differ in NaF/K3EDTA and NaF/KOX plasma (P = 0.855). No clinically significant difference of AHP compared 
to NaF/K3EDTA lactate was found (y = 0.13 (0.08 to 0.19) + 1.02 (0.99 to 1.08) x) if samples were aliquoted within 30 minutes after venipuncture. On 
contrary, lactate concentrations in HP showed significant proportional difference (y = 0.07 (- 0.12 to 1.24) + 1.37 (1.22 to 1.56) x) and were clinically 
incorrect in 14% of patients. Transport in ice bath increases HI in NaF/K3EDTA (P < 0.001), but without influencing lactate results compared to room 
temperature (y = 0.03 (- 0.06 to 1.00) + 1.05 (0.99 to 1.11) x).
Conclusions: Lactate determination in HP is unacceptable because of high proportional error and high risk of clinical inaccuracy compared to NaF/
K3EDTA. If pre-analytical conditions are met, AHP, NaF/K3EDTA and NaF/KOX plasma can be used interchangeably. Aliquoted Li-heparin samples alow 
measurement of other biochemical tests from a single tube and can spare ICU patients from additional blood drawing. Storage in ice bath provides 
no additional stabilization in NaF/K3EDTA tubes.
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Introduction 
Blood lactate is a commonly ordered blood test 
for critically ill patients in intensive care units (ICU) 
with high risk of multiple organ failure following 
cardiogenic, haemorrhagic or septic shock and 
acute pulmonary insufficiency (1). Increased blood 
lactate is an early warning indicator of impaired 
tissue perfusion and oxygenation which makes 
lactate an important urgent test for directly as-
sessing the shock severity and mortality rates (2). 
Acute changes in lactate concentrations can influ-
ence clinical management and application of ther-
apy, so lactate measurements might be performed 
from 2 - 3 times per day to every 1 - 2 hours in 
acute conditions (2). Decreasing or persistently 
low concentrations of blood lactate during critical 
illness signify a favourable prognosis (3). However, 
frequent blood sampling and copious amounts of 
blood drawn represent a serious problem due to 
the phlebotomy related blood loss in ICU patients 
(4). 
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According to the Clinical and Laboratory Stand-
ards Institute (CLSI) guidelines, in order to obtain 
rapid results, it is recommended to use biosensor-
based electrochemical whole blood lactate meas-
urements at the point-of-care testing system 
(POCT), utilizing capillary or arterial whole blood 
drawn in a heparinized capillary tube or syringe 
(5). However, in our country many hospitals still 
use plasma for lactate determination in a central 
laboratory (6). In this setting it is imperative to de-
fine the pre-analytical factors that affect the reli-
ability of plasma lactate.
The most critical factors that influence lactate re-
sults are stabilizing additives (antiglycolytic 
agents), temperature and time of storage. Sodium 
fluoride (NaF) is the most common used stabilizer 
to prevent changes in lactate concentration (7). 
NaF inhibits the glycolytic enzyme enolase and is 
usually used in combination with an anticoagulant 
such as potassium oxalate (KOX), ethylenediami-
netetraacetic acid (EDTA), lithium heparin (Li-hep-
arin) or citrate (8). KOX has an additional inhibitory 
effect by inhibiting pyruvate kinase (9). For lactate 
determination, the reagent manufacturers recom-
mend NaF/KOX or NaF/Na-heparin plasma (10). Al-
though different combinations of stabilizing addi-
tives are offered by manufacturers, their mutual 
comparison is unknown.
Other factors that influence accurate lactate deter-
mination are temperature and storage. Clinical 
and Laboratory Standards Institute guidelines rec-
ommend placing the drawn blood sample in an 
ice bath immediately after stasis-free venepunc-
ture, and centrifugation within 15 minutes (11). 
However, it was previously shown that storage on 
ice provides no additional stabilization compared 
to room temperature when blood is obtained cor-
rectly in tubes containing NaF/KOX (7). Li-heparin 
plasma is also acceptable, but blood must be tak-
en on ice and plasma separated from cells within 
15 minutes of collection (10). Additionally, placing 
the blood in an ice bath immediately after ve-
nepuncture can cause haemolysis which might af-
fect lactate results and other biochemical tests in 
plasma. Due to the activity of glycolytic enzymes 
together with a certain amount of lactate released 
from ruptured erythrocytes, haemolysis may also 
have an impact on final lactate concentration by 
increasing lactate concentrations which opposes 
the desired ice-cooling effect (12). Although man-
ufacturers of lactate assays declare interference of 
haemolysis index, the biological interference of 
haemolysis on plasma lactate is unclear.
The aim of our study was to assess the key pre-an-
alytical elements which affect the reliability of ob-
tained plasma lactate concentration. Effects of dif-
ferent stabilizing additives, aliquoting, ice storage 
and haemolysis were evaluated in three separate 
comparison studies with specific goals: I) to estab-
lish if we can use test tubes with different addi-
tives for lactate determination by comparing plas-
ma lactate in NaF/K3EDTA and NaF/KOX tubes, ini-
tially and after 24 hours storage; II) to compare lac-
tate concentration in NaF/K3EDTA tubes transport-
ed at room temperature with concentrations in 
the same tubes stored in ice bath and to investi-
gate the influence of resulting haemolysis on plas-
ma lactate concentrations; III) to assess if ICU pa-
tients can be spared an extra blood draw for lac-
tate determination by comparing lactate concen-
tration in Li-heparin plasma (HP) also routinely 
used for other urgent biochemical tests, Li-heparin 




This is prospective experimental study which in-
cludes three separate comparison studies: I) com-
parison of lactate in NaF/K3EDTA and NaF/KOX 
tubes; II) comparison of lactate concentration in 
NaF/K3EDTA tubes transported ice bath and at 
room temperature; and III) comparison of lactate 
values in HP, AHP and NaF/K3EDTA plasma. The 
study was performed on samples collected from 
March 2015 to March 2016, at University Hospital 
Centre Zagreb. 
The study was performed according to the re-
quirements of the Declaration of Helsinki, follow-
ing the approval of our institution’s ethics commit-
tee. Informed consent was obtained from all par-
ticipants.
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Subjects
A total number of subjects in all comparison stud-
ies was 177 (122 males and 55 females; median age 
65, range 16 – 83 years).
Twenty participants (11 males and 9 females; me-
dian age 43, range 25 – 72 years) were included in 
comparison of lactate concentrations in NaF/K3ED-
TA and NaF/KOX test tubes. Seven were patients 
from the Department of Thoracic Surgery, and 
others were volunteers. We have included both 
patients and volunteers to reflect populations of 
two other comparison studies.
Pre-analytical stability of lactate in samples drawn 
in NaF/K3EDTA tubes was tested in 50 outpatients 
(26 males and 24 females; median age 61, range 16 
– 83 years) by comparing the lactate concentration 
in the tube placed in ice bath directly after veni-
puncture and tube stored at room temperature 
before sample processing. 
Comparison of lactate concentrations in HP, AHP 
and NaF/K3EDTA plasma were performed in sam-
ples of 107 patients (85 males and 22 females; me-
dian age 67, range 34 – 82 years) with suspected 
hypo perfusion or hypoxia from the Department 
of Thoracic Surgery Intensive Care.
Blood sampling
For all samples, blood was collected with minimal 
stasis and centrifuged for 10 minutes at 2000 x g 
on a centrifuge Rotofix 32A (Hettich GmbH, Tut-
tlingen, Germany) within 15 minutes from veni-
puncture. Depending on the study design, tubes 
with NaF/K3EDTA (2mL), NaF/KOX (2mL) and Li-
heparin (4mL) anticoagulants (Greiner Bio-One 
GmbH, Kremsmünster, Austria) were used.
For comparison of lactate in NaF/K3EDTA and NaF/
KOX tubes, samples were collected in the morning 
hours after an overnight fast and sent to the labo-
ratory at room temperature. 
For comparison of lactate concentration in NaF/
K3EDTA tubes transported at room temperature 
and in an ice bath, samples were collected in the 
morning hours after an overnight fast. To avoid 
haemolysis due to blood sampling, none of these 
tubes was the first sampling tube for outpatients. 
For comparison of lactate in HP, AHP and NaF/
K3EDTA plasma, samples were collected at any 
time of the day no matter the fasting state and 
sent to the laboratory at room temperature. Con-
trary to the CLSI guidelines we omitted storing Li-
heparin and NaF/K3EDTA tubes in an ice bath to 
avoid possible haemolysis as HP sample was also 
used for other urgent biochemistry tests (11). This 
study also served for evaluation of possible spar-
ing of excess blood draw for ICU patients. Li-hepa-
rin plasma was aliquoted immediately after cen-
trifugation. 
Methods
All lactate measurements were carried out on Co-
bas c501 analyser (Roche Diagnostics GmbH, Man-
nheim, Germany) using the commercially available 
reagent Lactate Gen.2 (Roche Diagnostics GmbH, 
Mannheim, Germany). The manufacturer of the 
Lactate Gen.2 assay validated its performance on 
the Cobas c501 analyser with those determined 
using the same reagent on a Roche/Hitachi 917 an-
alyser. A short verification of the method perfor-
mance was performed in our laboratory before 
the study was conducted, according to HRN EN 
ISO 15189:2012 Medical laboratories - Require-
ments for quality and competence. During the 
1-year study period, plasma lactate assay precision 
(CV) and accuracy (BIAS) were less than 2% and 
sigma value > 6. Quality control was performed 
every 12 hours using normal and high concentra-
tions of commercially available control material 
(PreciControl ClinChem Multi 1 and PreciControl 
ClinChem Multi 2, Roche Diagnostics GmbH, Man-
nheim, Germany).
Haemolysis index (HI) was determined and quanti-
fied on Cobas c501 analyser using the commercial-
ly available reagent Serum Index Gen.2 (Roche Di-
agnostics GmbH, Mannheim, Germany). Haemoly-
sis index of 10 corresponds to a haemoglobin con-
centration of 0.1 g/L. Manufacturer of lactate assay 
declares no significant interference up to HI of 1000.
For comparison of lactate in NaF/K3EDTA and NaF/
KOX tubes, after blood sampling and centrifuga-
tion, NaF/K3EDTA and NaF/KOX primary tubes 
were immediately placed on the analyser and 
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analysis was completed in about 1 hour after the 
draw time. Following the initial measurement, the 
samples were stored for 24 hours at 2 - 8 °C. After-
wards, the lactate measurement was repeated to 
compare the antiglycolytic effect of tube addi-
tives.
For comparison of lactate in NaF/K3EDTA tubes 
transported at room temperature and in ice bath 
samples, NaF/K3EDTA primary tubes were used for 
lactate and HI measurement and results were ob-
tained within 1 hour from venipuncture.
For comparison of lactate concentrations in HP, 
AHP and NaF/K3EDTA plasma, Li-heparin tubes 
were aliquoted immediately after centrifugation 
and lactate was measured in AHP and HP at the 
same time with NaF/K3EDTA primary tube. Results 
were obtained within 1 hour from venipuncture at 
the same time for three parallel samples.
Statistical analysis
Data were tested for normality using the Kolmog-
orov-Smirnov test. Statistical differences in data 
that did not follow normal distribution, and lower 
sample size data (N < 30), were tested using the 
Wilcoxon’s rank sum test for paired samples. Nor-
mally distributed data were tested for statistical 
differences with paired samples t-test. The compa-
rability of results was tested using Passing-Bablok 
regression analysis and Bland-Altman analysis. 
Within-subject biological variation for lactate is 
27% (13). Therefore differences in compared tubes 
higher than 27% were considered clinically signifi-
cant. Pearson correlation was used to test the as-
sociation of delta HI (HI in ice bath sample – HI in 
room temperature sample) and delta NaF/K3EDTA 
lactate (lactate in an ice bath sample – lactate at 
room temperature sample) between tubes trans-
ported at different temperatures. A P value < 0.05 
was set as a level of statistical significance. Statisti-
cal analysis was performed using MedCalc Soft-
ware v. 9.3.2.0. (Ostendt, Belgium). The clinical ac-
curacy of lactate measured in HP and AHP com-
pared to NaF/K3EDTA concentrations was assessed 
based on reference interval and clinical decision 
limits. Values were considered inaccurate if lactate 
in the compared tube (HP, AHP) was above the up-
per limit of reference interval (2.2 mmol/L), unlike 
the NaF/K3EDTA lactate. If the concentration of lac-
tate increases beyond 3 – 4 mmol/L, there is an in-
creased risk of associated acidosis and the possible 
need for therapy (14). At our institution, the con-
centration of 3 mmol/L is used as the limit of clini-
cal decision-making. Therefore, if the lactate con-
centration in the compared tube was > 3 mmol/L, 
while the reference NaF/K3EDTA plasma lactate 
concentrations were < 3 mmol/L or within the ref-
erence interval, this measurement was considered 
highly inaccurate as the decisions based on this 
value could potentially cause patient mistreat-
ment.
Results
The measured lactate concentrations in NaF/K3ED-
TA and NaF/KOX tubes ranged from 0.5 to 2.3 
mmol/L. Median and interquartile range (IQR) for 
different tubes, both initially and after 24 hours, 
are shown in Table 1. No statistical difference in 
lactate results or measured lactate concentration 
between NaF/K3EDTA and NaF/KOX tubes, both, in 
initial sample (P = 0.855) and 24 hours (P = 0.626) 
was found.
Passing-Bablok regression analysis showed no 
proportional nor constant error in determining 
lactate concentration between the two tubes with 
different anticoagulants, both in initial measure-
ment and after 24 hours (Figure 1). Mean differ-
ence in lactate concentration after 24 hours was 
0.25 mmol/L for both test tube types (Figure 2).
Lactate concentrations measured in NaF/K3EDTA 
tubes placed in ice bath were significantly lower 
than those measured in tubes stored at room tem-
perature (P < 0.001). Mean value and standard de-
viation (SD) for plasma lactate results and HI ob-
tained at different storage temperature is shown 
in Table 1. However, there was no proportional nor 
constant error obtained by Passing-Bablok analy-
sis between the two tested temperature transport 
conditions. Haemolysis index was higher in tubes 
that were transported in an ice bath (HI mean dif-
ference 9, P < 0.001) (Figure 3). We did not find any 
correlation between delta HI and delta lactate 
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STUDY 1 (N = 20)
NaF/K3EDTA NaF/KOX P*
Initial lactate concentration (mmol/L) 1.1 (0.7 - 1.6) 1.1 (0.7 - 1.5) 0.855
Lactate after 24 h (mmol/L) 1.2 (1.0 - 1.9) 1.3 (1.0 - 1.8) 0.626






Lactate (mmol/L) 1.2 (± 0.49) 1.3 (± 0.51) < 0.001
Haemolysis index 25 ± 12 16 ± 8 < 0.001






Lactate (mmol/L) 1.0 (0.8 - 1.3)
1.1 
(1.0 - 1.5) < 0.001
1.6 
(1.3 - 2.0) < 0.001
Study 1 - comparison of lactate in NaF/K3EDTA and NaF/KOX tubes at baseline and after 24 h of storage. Study 2 - comparison 
of lactate concentration and haemolysis index in NaF/K3EDTA tubes at different transport temperature conditions. Study 3 - 
comparison of lactate values in HP, AHP and NaF/K3EDTA plasma. Data are presented as a median and interquartile range (IQR) or 
mean and standard deviation (SD) depending on sample size and the normality of distribution. P < 0.05 was considered statistically 
significant. AHP - aliquoted heparin plasma. HP - heparin plasma. *Wilcoxon’s rank sum test. †Paired samples t-test.
Table 1. Lactate results in different pre-analytical conditions
Figure 1. Comparison of lactate measured in NaF/K3EDTA and NaF/KOX plasma using Passing-Bablok regression analysis. (A) Initial 
lactate concentrations. (B) Lactate concentrations after 24 hour storage. The regression line equation (Y = A (95% CI) + B (95% CI) x) 
is shown in the box. 95% CI – confidence intervals of 95%. A - regression line’s intercept. B - regression line’s slope. Solid line - regres-
sion line. Dashed lines - 95% CI for the regression line. Dotted line - identity line (x = y).
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concentration in tubes transported at room tem-
perature and an ice bath (r = 0.20; P = 0.156).
Lactate concentrations measured in AHP, HP and 
NaF/K3EDTA were between 0.3 and 11.3 mmol/L. 
The results are shown in Table 1. Wilcoxon’s rank 
sum test results showed a statistically significant 
difference in the concentration of lactate meas-
ured in AHP and HP compared to NaF/K3EDTA (P < 
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Figure 2. Comparison of lactate measured in (A) NaF/K3EDTA and (B) NaF/KOX plasma using the Bland-Altman analysis. Solid line 
(mean) – mean difference. Dashed lines (SD) – standard deviation. A mean difference of 0.25 mmol/L in lactate concentration after 
24h storage in both tubes was found.
Figure 3. (A) Passing-Bablok regression analysis showing the comparison of lactate measured in NaF/K3EDTA tubes put in ice water 
bath compared to tubes kept at room temperature. The regression line equation (Y = A (95% CI) + B (95% CI) x) is shown in the box. 
95% CI – confidence intervals of 95%. A - regression line’s intercept. B - regression line’s slope. Solid line - regression line. Dashed lines 
- 95% CI for the regression line. Dotted line - identity line (x = y). (B) Bland-Altman analysis showing the comparison of haemolysis 
index (HI) measured in ice bath and room temperature conditions.  Solid line (mean) – mean difference. Dashed lines (SD) – standard 
deviation. A mean difference of 9 in samples that were put in ice water bath after venipuncture compared to samples that were kept 
at room temperature was found. 
0.001). Passing-Bablok regression analysis of val-
ues in AHP compared to NaF/K3EDTA showed a 
constant error of 0.13 mmol/L in lactate concentra-
tion. Also, there was a high proportional error of 
1.37 between HP compared to NaF/K3EDTA (Figure 
4). HP lactate concentrations were clinically inac-
curate in 14% of patients. All lactate concentra-
tions measured in AHP were accurate based on 
clinical criteria (Table 2).
Discussion
In this study, we investigated the influence of dif-
ferent test tube additives, aliquoting, ice storage 
and haemolysis on plasma lactate concentrations 
through three different comparison studies.
Although manufacturers offer different test tubes 
and additives for plasma lactate determination, 
NaF/K3EDTA tube is not recommended by the 
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manufacturer of the lactate assay. We showed that 
lactate concentration in NaF/K3EDTA is compara-
ble to the recommended NaF/KOX plasma. To the 
best of our knowledge, we were unable to find any 
previous comparison studies with recommended 
tube. It was previously shown that lactate is stable 
in NaF/KOX at least 30 min at room temperature 
before centrifugation with the increase of only 0.2 
mmol/L during the first hour at room temperature 
(7). Interestingly, we also observed no difference in 
lactate in NaF/KOX and NaF/K3EDTA tubes even af-
ter 24 hours of storage. These results confirm the 
previously reported stability of lactate collected in 
the tube with NaF stabilizer and stored at + 4 °C 
(15). These combinations of stabilizing additives 
have an equal antiglycolytic effect and very 
strongly inhibit lactate production in vitro for an 
extended period.
In the second study, we compared lactate concen-
tration in NaF/K3EDTA tubes transported at room 
temperature with those in an ice bath. We con-
firmed that either way of temperature processing 
Figure 4. Comparison of results using Passing-Bablok regression analysis. (A) Li-heparin plasma aliquot and NaF/K3EDTA and (B) 
heparin plasma and NaF/K3EDTA. The regression line equation (Y = A (95% CI) + B (95% CI) x) is shown in the box. 95% CI – confidence 
intervals of 95%. A - regression line’s intercept. B - regression line’s slope. Solid line - regression line. Dashed lines - 95% CI for the re-
gression line. Dotted line - identity line (x = y).
Lactate (mmol/L)
NaF / K3EDTA
0.5 – 2.20 2.21 – 3.0 > 3.01
HP
0.5 – 2.20 89 0 0
2.21 – 3.0 10 1 0
> 3.01 2 3 2
AHP
0.5 – 2.20 101 0 0
2.21 – 3.0 0 4 0
> 3.01 0 0 2
The clinical accuracy was assessed based on reference interval (0.5 - 2.2 mmol/L) and clinical decision limits (> 3 mmol/L). Values 
were considered inaccurate if lactate in the compared tube (HP, AHP) was above the upper limit of reference interval or > 3 
mmol/L, unlike the NaF/K3EDTA lactate.  AHP - aliquoted heparin plasma. HP - heparin plasma.
Table 2. Clinical accuracy of lactate measured in HP and AHP compared to NaF/K3EDTA plasma
y = 0.13 (0.08 to 0.19)


























y = 0.07 (- 0.12 to 1.24)











































2 4 6 8 10 12
Biochem Med (Zagreb) 2018;28(2):020701  https://doi.org/10.11613/BM.2018.020701 
8
Rako I. et al. Plasma lactate concentration – preanalytical phase
would not lead to a clinically different result. Our 
results are in accordance with the previous studies 
that showed that separating plasma from cells and 
its storage in ice bath are not necessary for lactate 
stability when blood is drawn with the stabilizer 
(7,16). Haemolysis can influence lactate results in 
the plasma stabilized with NaF/KOX, but there are 
no findings about correlation between HI and the 
lactate concentration (17). Our results showed that 
samples transported in ice bath had statistically 
higher haemolysis index compared to those trans-
ported at room temperature. However, difference 
in haemolysis does not correlate with the differ-
ences in lactate concentrations obtained at differ-
ent transport temperatures. The impact of hae-
molysis index on plasma lactate concentration is 
highly individual and depends on a number of fac-
tors that can influence lactate metabolism in vitro: 
temperature, time, oxygen content in the sample, 
content of haemoglobin and the number of blood 
cells which act as reservoirs of glycolytic enzymes 
that increase lactate during sample storage (1,18). 
Unlike the measurement of plasma lactate on bio-
chemistry analyser, point-of-care testing (POCT) of 
whole blood lactate is the more pragmatic ap-
proach and increasingly justified based on medi-
cal benefits (19). However, many hospitals still use 
plasma sample because POCT is not established or 
financially feasible, especially for frequent lactate 
determination. Furthermore, in some cases, colori-
metric measurements of lactate in arterial or ve-
nous plasma can perform better than potentiom-
etry in whole blood because of less analytical in-
terferences (9, 20-22). Despite this, studies on pre-
analytical effects on plasma lactate measurement 
are scarce. 
For ICU patients it is necessary to perform com-
plete laboratory testing several times a day for es-
timating patient clinical status (23). The organ dys-
function can be assessed using different scoring 
systems that quantify abnormalities according to 
clinical findings, laboratory data or therapeutic in-
terventions. The predominantly current use scor-
ing system is SOFA (Sequential Organ Failure As-
sessment). Laboratory tests as creatinine and bili-
rubin measured in heparin plasma are needed for 
score calculation. Additionally, lactate measure-
ments along with other urgent laboratory tests 
measured in the heparin plasma can help identify 
patients at risk (24). Guidelines recommend that 
lactate should either be measured in the whole 
blood by the POCT instrument or it is necessary to 
draw an additional tube with stabilizer for plasma 
testing (5,11). For this reason, we wanted to assess 
if ICU patients can be spared an extra blood draw 
for lactate determination by comparing lactate in 
Li-heparin plasma also routinely used for other ur-
gent biochemical tests. For HP, the observed pro-
portional error of 37% is unacceptable considering 
the established 27% within-subject biological vari-
ance for lactate (13). That error is particularly unac-
ceptable given the narrow reference interval for 
plasma lactate. We also made a clinical accuracy 
assessment of lactate results obtained in AHP and 
HP compared to NaF/K3EDTA plasma. Alarmingly, 
risk analysis for HP showed a moderate to high risk 
of clinical error in a high percentage of patients 
(14%). Therefore not-aliquoted Li-heparin plasma 
transported at room temperature is unsuitable for 
lactate determination (25). On contrary, clinical ac-
curacy analysis showed that same clinical decision 
would be made consistently based on the AHP lac-
tate concentrations. Therefore, AHP can be used 
for lactate determination which gives the oppor-
tunity of determining lactate from the same tube 
as other urgent biochemical tests and thus sparing 
ICU patients from an additional blood draw. To the 
best of our efforts, we were unable to find any sim-
ilar study to compare our findings.
We acknowledge that the current study has some 
potential limitations. To spare the patients of large 
amount of blood sampling for study purposes, our 
hypotheses were tested on three separate patient 
groups of different sample size. Furthermore, the 
study that compared NaF/K3EDTA and NaF/KOX 
lactate concentrations included only 20 patients. 
Also, the majority of patients have initial lactate 
concentrations in the normal range and entire 
concentration range is not equally represented. 
However, this study elucidates some dilemmas 
about the pre-analytical phase of plasma lactate 
determination regarding different additives, stor-
age in an ice bath and resulting haemolysis be-
cause no similar study has been reported. Addi-
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tionally, results of this study show the possibility to 
reduce blood sampling in ICU patients when plas-
ma lactate is ordered with other urgent biochemi-
cal tests. Also, these results contribute to the de-
velopment of the appropriate guidelines to be ap-
plied in clinical practice in the pre-analytical phase 
of plasma lactate determination.
We conclude that AHP, NaF/K3EDTA and NaF/KOX 
plasma can be used interchangeably for lactate 
determination under the certain pre-analytical 
conditions. It is not necessary to put test tubes in 
ice bath directly after venipuncture if blood is 
drawn with NaF/K3EDTA stabilizer and centrifuged 
within 15 minutes after venipuncture. If Li-heparin 
test tubes are transported at room temperature, 
plasma must be aliquoted immediately after cen-
trifugation. This algorithm avoids potential in vitro 
haemolysis due to ice-bath temperature condi-
tions and spares ICU patients from excessive blood 
sampling by allowing the measurement of all ur-
gent biochemical tests including lactate from a 
single Li-heparin tube. Lactate measurement in 
unaliquoted HP is unacceptable because of high 
proportional error and high risk of clinical inaccu-
racy in comparison to NaF/K3EDTA tubes.
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